Pharmacological inhibition of DNMT1 restores macrophage autophagy and M2 polarization in Western diet-induced nonalcoholic fatty liver disease

J Biol Chem. 2023 Jun;299(6):104779. doi: 10.1016/j.jbc.2023.104779. Epub 2023 May 2.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased ratio of classically activated M1 macrophages/Kupffer cells to alternatively activated M2 macrophages, which plays an imperative role in the development and progression of NAFLD. However, little is known about the precise mechanism behind macrophage polarization shift. Here, we provide evidence regarding the relationship between the polarization shift in Kupffer cells and autophagy resulting from lipid exposure. High-fat and high-fructose diet supplementation for 10 weeks significantly increased the abundance of Kupffer cells with an M1-predominant phenotype in mice. Interestingly, at the molecular level, we also observed a concomitant increase in expression of DNA methyltransferases DNMT1 and reduced autophagy in the NAFLD mice. We also observed hypermethylation at the promotor regions of autophagy genes (LC3B, ATG-5, and ATG-7). Furthermore, the pharmacological inhibition of DNMT1 by using DNA hypomethylating agents (azacitidine and zebularine) restored Kupffer cell autophagy, M1/M2 polarization, and therefore prevented the progression of NAFLD. We report the presence of a link between epigenetic regulation of autophagy gene and macrophage polarization switch. We provide the evidence that epigenetic modulators restore the lipid-induced imbalance in macrophage polarization, therefore preventing the development and progression of NAFLD.

Keywords: DNA hypomethylating agents; NAFLD; autophagy; epigenetic reprogramming; macrophage polarization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy* / drug effects
  • Autophagy* / genetics
  • Azacitidine / pharmacology
  • Azacitidine / therapeutic use
  • Cell Polarity* / drug effects
  • DNA Methylation / drug effects
  • Diet, High-Fat / adverse effects
  • Diet, Western / adverse effects
  • Enzyme Inhibitors / pharmacology
  • Epigenesis, Genetic / drug effects
  • Gene Knockdown Techniques
  • Liver / cytology
  • Liver / physiopathology
  • Macrophages* / drug effects
  • Macrophages* / metabolism
  • Mice
  • Non-alcoholic Fatty Liver Disease* / genetics
  • Non-alcoholic Fatty Liver Disease* / physiopathology
  • RAW 264.7 Cells

Substances

  • Azacitidine
  • pyrimidin-2-one beta-ribofuranoside
  • Enzyme Inhibitors
  • Dnmt1 protein, mouse